Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor

Open access
Elinav, Eran, Adam, Nitzan, Waks, Tova, Eshhar, Zelig · 2009 · Gastroenterology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2009.01.049

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 43

  1. Chen, 1998, Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4(+) T cells, J Exp Med, 188, 1849, 10.1084/jem.188.10.1849 · DOI · Paper page
  2. Hsieh, 2006, An intersection between the self-reactive regulatory and nonregulatory T-cell receptor repertoires, Nat Immunol, 7, 401, 10.1038/ni1318 · DOI · Paper page
  3. Tanchot, 2004, Immune regulation by self-reactive T cells is antigen specific, J Immunol, 172, 4285, 10.4049/jimmunol.172.7.4285 · DOI
  4. Shevach, 2002, CD4+ CD25+ suppressor T cells: more questions than answers, Nat Rev Immunol, 2, 389, 10.1038/nri821 · DOI · Paper page
  5. Asano, 1996, Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation, J Exp Med, 184, 387, 10.1084/jem.184.2.387 · DOI · Paper page
  6. Maul, 2005, Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease, Gastroenterology, 128, 1868, 10.1053/j.gastro.2005.03.043 · DOI · Paper page
  7. Mottet, 2003, Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells, J Immunol, 170, 3939, 10.4049/jimmunol.170.8.3939 · DOI · Paper page
  8. Hori, 2002, Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T-cell receptor transgenic mice, Proc Natl Acad Sci U S A, 99, 8213, 10.1073/pnas.122224799 · DOI · Paper page
  9. Masteller, 2006, Antigen-specific regulatory T cells—ex vivo expansion and therapeutic potential, Semin Immunol, 18, 103, 10.1016/j.smim.2006.01.004 · DOI
  10. Mekala, 2005, IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes, Proc Natl Acad Sci U S A, 102, 11817, 10.1073/pnas.0505445102 · DOI
  11. Elinav, 2008, Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice, Gastroenterology, 134, 2014, 10.1053/j.gastro.2008.02.060 · DOI · Paper page
  12. Li, 2005, CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy, Blood, 106, 3068, 10.1182/blood-2005-04-1531 · DOI
  13. Friedmann-Morvinski, 2005, Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation, Blood, 105, 3087, 10.1182/blood-2004-09-3737 · DOI
  14. Eshhar, 1993, Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ξ subunits of the immunoglobulin and T-cell receptors, Proc Natl Acad Sci U S A, 90, 720, 10.1073/pnas.90.2.720 · DOI · Paper page
  15. Becker, 2005, In vivo imaging of colitis and colon cancer development in mice using high-resolution chromoendoscopy, Gut, 54, 950, 10.1136/gut.2004.061283 · DOI · Paper page
  16. Pinthus, 2004, Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes, J Clin Invest, 114, 1774, 10.1172/JCI200422284 · doi:10.1172/jci200422284
  17. Pandiyan, 2007, CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells, Nat Immunol, 8, 1353, 10.1038/ni1536 · DOI · Paper page
  18. Erhardt, 2007, IL-10, regulatory T cells, and Kupffer cells mediate tolerance in Concanavalin A-induced liver injury in mice, Hepatology, 45, 475, 10.1002/hep.21498 · DOI · Paper page
  19. Hombach, 2007, Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2, J Immunol, 179, 7924, 10.4049/jimmunol.179.11.7924 · DOI
  20. Kim, 2007, Generation and maturation of bone marrow-derived DCs under serum-free conditions, J Immunol Methods, 323, 101, 10.1016/j.jim.2007.03.005 · doi:10.1016/j.jim.2007.03.005
  21. Malek, 2008, IL-2 family of cytokines in T regulatory cell development and homeostasis, J Clin Immunol, 28, 635, 10.1007/s10875-008-9235-y · DOI
  22. Moriggl, 1999, Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells, Immunity, 10, 249, 10.1016/S1074-7613(00)80025-4 · DOI · Paper page
  23. Banz, 2002, Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells, J Immunol, 169, 750, 10.4049/jimmunol.169.2.750 · DOI
  24. Weber, 2006, Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo, J Immunol, 176, 4730, 10.4049/jimmunol.176.8.4730 · DOI
  25. Huang, 2004, Role of LAG-3 in regulatory T cells, Immunity, 21, 503, 10.1016/j.immuni.2004.08.010 · DOI · Paper page
  26. Gondek, 2005, Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism, J Immunol, 174, 1783, 10.4049/jimmunol.174.4.1783 · DOI · Paper page
  27. Watanabe, 2002, Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver, J Immunol, 168, 2188, 10.4049/jimmunol.168.5.2188 · DOI
  28. Askenasy, 2005, Induction of tolerance using Fas ligand: a double-edged immunomodulator, Blood, 105, 1396, 10.1182/blood-2004-06-2364 · DOI
  29. Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J Immunol, 164, 183, 10.4049/jimmunol.164.1.183 · DOI · Paper page
  30. Piccirillo, 2001, Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells, J Immunol, 167, 1137, 10.4049/jimmunol.167.3.1137 · DOI · Paper page
  31. Sarween, 2004, CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion, J Immunol, 173, 2942, 10.4049/jimmunol.173.5.2942 · DOI
  32. Kuniyasu, 2000, Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation, Int Immunol, 12, 1145, 10.1093/intimm/12.8.1145 · DOI · Paper page
  33. Duthoit, 2005, Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes, J Immunol, 174, 155, 10.4049/jimmunol.174.1.155 · DOI
  34. Inaba, 2006, Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T lymphocytes, Int Immunol, 18, 1043, 10.1093/intimm/dxl038 · doi:10.1093/intimm/dxl038
  35. Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306 · DOI · Paper page
  36. Miyara, 2007, Natural regulatory T cells: mechanisms of suppression, Trends Mol Med, 13, 108, 10.1016/j.molmed.2007.01.003 · DOI · Paper page
  37. Gavin, 2007, Foxp3-dependent programme of regulatory T-cell differentiation, Nature, 445, 771, 10.1038/nature05543 · DOI · Paper page
  38. Kim, 2007, Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells, Biochem Biophys Res Commun, 362, 44, 10.1016/j.bbrc.2007.07.187 · DOI
  39. Allan, 2008, CD4+ T-regulatory cells: toward therapy for human diseases, Immunol Rev, 223, 391, 10.1111/j.1600-065X.2008.00634.x · DOI · Paper page
  40. Brusko, 2008, Human regulatory T cells: role in autoimmune disease and therapeutic opportunities, Immunol Rev, 223, 371, 10.1111/j.1600-065X.2008.00637.x · DOI · Paper page
  41. Elpek, 2007, Ex vivo expansion of CD4+CD25+FoxP3+ T-regulatory cells based on synergy between IL-2 and 4-1BB signaling, J Immunol, 179, 7295, 10.4049/jimmunol.179.11.7295 · DOI
  42. Montcuquet, 2008, Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells, Immunology, 125, 320, 10.1111/j.1365-2567.2008.02843.x · DOI
  43. Kang, 2007, CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects, Am J Transplant, 7, 1457, 10.1111/j.1600-6143.2007.01829.x · DOI · Paper page

Cited by

See all 168

Metadata

Authors
Elinav, E., Adam, N., Waks, T., & Eshhar, Z.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2009-05
Volume
136
Issue
5
Pages
1721-1731
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2136365031
Cited by
168
References
3
FWCI
1.78
Type
journal article
Language
en
Open access
bronze
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor. https://app.cochat.ai/papers/10.1053/j.gastro.2009.01.049
The paper
Elinav, E., Adam, N., Waks, T., & Eshhar, Z. (2009). Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor. Gastroenterology. https://doi.org/10.1053/j.gastro.2009.01.049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.